Phocas Financial Corp. boosted its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 30.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 94,320 shares of the company's stock after buying an additional 22,095 shares during the period. Phocas Financial Corp. owned approximately 0.10% of Acadia Healthcare worth $3,740,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors have also recently bought and sold shares of ACHC. FMR LLC boosted its position in Acadia Healthcare by 257.9% in the 4th quarter. FMR LLC now owns 6,230,631 shares of the company's stock worth $247,045,000 after purchasing an additional 4,489,681 shares in the last quarter. Madison Avenue Partners LP purchased a new stake in Acadia Healthcare in the 4th quarter worth approximately $76,339,000. Sachem Head Capital Management LP purchased a new stake in Acadia Healthcare in the 4th quarter worth approximately $52,734,000. Khrom Capital Management LLC purchased a new stake in Acadia Healthcare in the 4th quarter worth approximately $49,602,000. Finally, Balyasny Asset Management L.P. purchased a new stake in Acadia Healthcare in the 4th quarter worth approximately $43,092,000.
Analyst Ratings Changes
Several equities research analysts have commented on the company. Guggenheim initiated coverage on Acadia Healthcare in a research report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price objective on the stock. Barclays decreased their target price on Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research report on Wednesday, May 14th. Bank of America decreased their target price on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. Royal Bank of Canada decreased their target price on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research report on Monday, March 3rd. Finally, Mizuho decreased their target price on Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating on the stock in a research report on Wednesday, May 14th. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the company's stock. Based on data from MarketBeat, Acadia Healthcare presently has an average rating of "Moderate Buy" and an average target price of $47.94.
Get Our Latest Stock Analysis on Acadia Healthcare
Acadia Healthcare Price Performance
NASDAQ ACHC traded down $0.08 during mid-day trading on Friday, hitting $22.77. The stock had a trading volume of 1,666,930 shares, compared to its average volume of 1,718,120. The firm's 50 day moving average is $25.09 and its 200 day moving average is $34.31. Acadia Healthcare Company, Inc. has a twelve month low of $20.36 and a twelve month high of $82.41. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The stock has a market capitalization of $2.10 billion, a price-to-earnings ratio of 7.47, a PEG ratio of 1.46 and a beta of 1.01.
Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Monday, May 12th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.35 by $0.05. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. The firm had revenue of $770.51 million during the quarter, compared to the consensus estimate of $769.90 million. During the same period in the prior year, the company earned $0.84 EPS. The firm's revenue was up .3% compared to the same quarter last year. Equities research analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.
Acadia Healthcare Company Profile
(
Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Read More

Before you consider Acadia Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.
While Acadia Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.